Results of treatment of two patients with MALT lymphoma

Introduction. MALT lymphoma is a rare histological type of malignant lung disease that develops from lymphoid tissue. This type of lymphoma belongs to the non-Hodgkin lymphomas. Given the lack of a standardized treatment protocol for patients with pulmonary MALT lymphoma, this study presents a case observation of the treatment of this disease. Each case observation is crucial for establishing a unified treatment strategy.

Aim. To demonstrate the effectiveness of comprehensive treatment in two patients with pulmonary MALT lymphoma.

Methods. This study presents two clinical cases of successful treatment of patients with MALT lymphoma at the regional clinical oncological dispensary in Ulyanovsk. The authors present their observations and describe the treatment regimens used. One patient underwent a tumor biopsy, which was inconclusive. Given the non-specific clinical presentation and the CT findings of a mass in the right lung with an undetermined histogenesis, as well as mediastinal involvement, surgical intervention was indicated for the morphological diagnosis of the lung mass. In both cases, targeted support with Rituximab was included in the treatment regimen. One case involved five courses of R-B therapy without progression, while in the other case, targeted therapy is planned as the next step after polychemotherapy.

Conclusions. MALT lymphoma is a rare nosological form. According to the authors, the most optimal treatment method is a combined approach, which includes surgical treatment, polychemotherapy, and subsequent targeted therapy.

1. Toneev EA, Martynov AA, Charyshkin AL, Bazarov DV, Lazarevskiy MM. Surgery in combined treatment of pulmonary malt-lymphoma. Ulyanovsk Medico-Biological Journal. 2018;3:87–93. (In Russ.) https://doi.org/10.23648/UMBJ.2018.31.17219.

2. Wise LM, Arkfeld DG. A patient with primary Sjogren’s syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review. Clin Rheumatol. 2020;39(4):1357–1362. https://doi.org/10.1007/s10067-019-04886-7.

3. Guo Z, Hu L, Chen Q, Hu J, Liu J, Hu W. Synchronous pulmonary MALT lymphoma and squamous cell lung cancer: a case report. World J Surg Oncol. 2023;21(1):182. https://doi.org/10.1186/s12957-023-03069-8.

4. Frolova IG, Vesnina VO, Velichko SA, Goldberg AV, Popova MV, Tabakaev SA et al. MALT-Lymphoma with Impairment of Lung, Pleura and Mediastinum Lymph Nodes: Clinical Observation. Journal of Oncology: Diagnostic Radiology and Radiotherapy. 2018;1(4):92–100. (In Russ.) Available at: https://www.oncoradjournal.ru/jour/article/view/85/85.

5. Le Y, Zhu H, Ye C, Lin J, Wang N, Yang T. CT radiomics analysis discriminates pulmonary lesions in patients with pulmonary MALT lymphoma and nonpulmonary MALT lymphoma. Methods. 2024;224:54–62. https://doi.org/10.1016/j.ymeth.2024.02.003.

6. Kou L, Huan NC, Nyanti LE, Chin JS, Mohamad NB, Ramarmuty HY. Pulmonary extra-nodal mucosa-associated lymphoid tissue (MALT) lymphoma: A rare cause of persistent lung consolidation. Respirol Case Rep. 2023;11(8):e01197. https://doi.org/10.1002/rcr2.1197.

7. Dong C, Xia P, Qiu W, Dai Z, Wang Z. Evaluation of CT features for differentiating consolidation pattern of pulmonary MALT lymphoma from pneumonic-type lung adenocarcinoma. Front Oncol. 2023;13:1234291. https://doi.org/10.3389/fonc.2023.1234291.

8. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;52(8):1410–1416. https://doi.org/10.1002/1097-0142(19831015)52:8<1410::aidcncr2820520813>3.0.co;2-3.

9. Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101(7):2489–2495. https://doi.org/10.1182/ blood-2002-04-1279.

10. Di Rocco A, Petrucci L, Assanto GM, Martelli M, Pulsoni A. Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment. Cancers. 2022;14(7):1742. https://doi.org/10.3390/cancers14071742.

11. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. NonHodgkin’s Lymphoma Classification Project. J Clin Oncol. 1998;16(8):2780–2795. https://doi.org/10.1200/JCO.1998.16.8.2780.

12. Borie R, Antoine M, Cadranel J, Wislez M. Pulmonary malt lymphoma. Bull Cancer. 2014;101(2):195–202. https://doi.org/10.1684/bdc.2014.1885.

13. Sehn LH, Salles G. Diffuse Large B-Cell Lymphoma. N Engl J Med. 2021;384(9):842–858. https://doi.org/10.1056/NEJMra2027612.

14. Kikuchi M, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H et al. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. J Chemother. 2015;27(2):99–105. https://doi.org/10.1179/1973947814Y.0000000219.

15. Starr AG, Caimi PF, Fu P, Massoud MR, Meyerson H, Hsi ED et al. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era. Br J Haematol. 2016;175(2):275–280. https://doi.org/10.1111/bjh.14228.

16. Zhang CS, Yang XR, Ding W, Lu XY, Shen L, Zhao YF. Pulmonary mucosaassociated lymphoid tissue lymphoma concurrent with lung squamous cell carcinoma: a case report and literature review. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(12):1071–1076. https://doi.org/10.3760/cma.j.cn11214720200729-00859.

17. Becnel MR, Nastoupil LJ, Samaniego F, Davis RE, You MJ, Green M et al. Lenalidomide plus rituximab (R2) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial. Br J Haematol. 2019;185(5):874–882. https://doi.org/10.1111/bjh.15843.

18. Ishikawa E, Nakamura M, Satou A, Shimada K, Nakamura S. MucosaAssociated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era. Cancers. 2022;14(2):446. https://doi.org/10.3390/cancers14020446.

19. Filip PV, Cuciureanu D, Diaconu LS, Vladareanu AM, Pop CS. MALT lymphoma: epidemiology, clinical diagnosis and treatment. J Med Life. 2018;11(3):187–193. https://doi.org/10.25122/jml-2018-0035.

20. Wang Y, He Z, Zhu Z, Luo R. Primary pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type: a case report and literature review. Am J Transl Res. 2022;14(12):9072–9077. Available at: https://pubmed.ncbi.nlm.nih.gov/36628239/.